Isolate single cells reliably and cost-effectively
SEED Biosciences SA
Incorporated
04.09.2018Headquarters
EpalingesSupport
DispenCell is an enabler for personalized medicine as it allows scientists to isolate single cells reliably and cost-effectively by reducing lab time and validation time.
News
Innosuisse funds 33 projects as part of the Swiss Accelerator (startupticker.ch)
Innosuisse Scale-up Coaching programme to boost 17 start-ups (startupticker.ch)
Swiss startups accelerate precision medicine and value-based healthcare (startupticker.ch)
Major business partner for SEED Biosciences (startupticker.ch)
The 18 most promising biotech startups, according to investors (TOP 100)
SEED Biosciences DispenCell US expansion gets boost (startupticker.ch)
New prizes for Swiss start-ups (startupticker.ch)
One million Swiss francs for SEED Biosciences (startupticker.ch)
SEED Biosciences completes CHF 1 million Series A financing round (venturelab.swiss)
SEED Biosciences and Xsensio join Merck Accelerator (startupticker.ch)
SEED Biosciences au c’ur d’un projet d'immunothérapie franco-suisse (startupticker.ch)
SEED Biosciences and Andrew Alliance receive innovation awards in Washington (startupticker.ch)
Swiss startups take on the US East Coast (startupticker.ch)
SEED Biosciences joins three talented ventures at StartLab (startupticker.ch)
CHF 260?000 for two medtech startups (startupticker.ch)
Milestones news
Videos and Presentations
SEED Biosciences - We make DispenCell
Startup Champions Seed Night 2017
DispenCell Movie